Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoP(c) expressing urease A and B subunits

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 581-586

  Corthésy Theulaz, Irène E ^a   Hopkins, Sally ^b   Bachmann, Daniel ^a   Saldinger, Pierre F ^a   Porta, Nadine ^a   Haas, Rainer ^c   Zheng Xin, Yan ^d   Meyer, Thomas ^d   Bouzourène, Hanifa ^e   Blum, André L ^a   Kraehenbuhl, Jean Pierre ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INST FÜR BIOLOGIE   (Germany)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

UREASE;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL INFECTION; CELL PROTECTION; CONTROLLED STUDY; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA TYPHIMURIUM;

EID: 2642708349     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.581-586.1998     Document Type: Article

References (44)

1. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5-24.
2. Corthésy-Theulaz, I., N. Porta, M. Glauser, E. Saraga, A. C. Vaney, R. Haus, J. P. Kraehenbuhl, A. L. Blum, and P. Michetti. 1995. Oral immunization with Helicobacter pylori urease as a treatment against Helicobacter infection. Gastroenterology 109:115-121.
3. Cuenca, R., T. Blanchard, C. K. Lee, T. P. Monath, R. Redline, J. G. Nedrud, and S. J. Czinn. 1995. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 108:A78.
4. Curtiss, R. D., S. M. Kelly, and J. O. Hassan. 1993. Live oral avirulent Salmonella vaccines. Vet. Microbiol. 37:397-405.
5. Czinn, S. J., and J. G. Nedrud. 1991. Oral immunization against Helicobacter pylori. Infect. Immun. 59:2359-2363.
6. D'Elios, M. M., M. Manghetti, M. Decarli, F. Costa, C. T. Baldari, D. Burroni, J. L. Telford, S. Romagnani, and G. Delprete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967.
7. Doidge, C., I. Crust, A. Lee, F. Buck, S. Hazell, and U. Manne. 1994. Therapeutic immunisation against Helicobacter infection. Lancet 343:914-915.
8. Ferrero, R. L., J. M. Thiberge, M. Huerre, and A. Labigne. 1994. Recombinant antigens prepared from the urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:4981-4989.
9. Ferrero, R. L., J. M. Thiberge, and A. Labigne. 1997. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology 113:185-194.
10. Galen, J. E., O. G. Gomez-Duarte, G. A. Losonsky, J. L. Halpern, C. S. Lauderbaugh, S. Kaintuck, M. K. Reymann, and M. M. Levine. 1997. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15:700-708.
11. Haas, R., T. F. Meyer, and J. P. van Putten. 1993. Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol. Microbiol. 8:753-760.
12. Haneberg, B., D. Kendall, H. M. Amerongen, F. M. Apter, J.-P. Kraehenbuhl, and M. R. Neutra. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from focal mucosal surfaces, Infect, Immun. 62:15-23.
13. Hopkins, S., and J. P. Kraehenbuhl. Dendritic cells of the murine Peyer's patches colocalize with Salmonella typhimurium avirulent mutants in the subepithelial dome. In Fourth International Symposium on Dendritic Cells in Fundamental and Clinical Immunology, in press. Plenum Press, New York, N.Y.
14. Hopkins, S., J.-P. Kraehenbuhl, F. Schödel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhi-murium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
15. Karttunen, R. A., T. J. Karttunen, M. M. Yousfi, H. M. el-Zimaity, D. Y. Graham, and F. A. el-Zaatari. 1997. Expression of mRNA for interferongamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 32:22-27.
16. Kelsall, B. L., and W. Strober. 1996. Distinct populations of dendritic cells are present in the subepithelial dome of T cell regions of the murine Peyer's patch. J. Exp. Med. 183:237-247.
17. Kleanthous, H., T. Tibbits, T. J. Bakios, K. Georgopoulos, G. Myers, T. H. Ermak, J. Fox, and T. Monath. 1995. In vivo selection of a highly adapted H. pylori isolate and the development of an H. pylori mouse model for studying vaccine efficacy and attenuating lesions. Gut 37:A94.
18. Lee, A., and M. Chen. 1994. Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine. Infect. Immun. 62:3594-3597.
19. Lee, C. K., R. Weltzin, W. D. Thomas, H. Kleanthous, T. H. Ermak, G. Soman, J. E. Hill, S. K. Ackerman, and T. P. Monath. 1995. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:161-172.
20. Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Baqar, M. F. Edwards, and B. Stocker. 1987. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 79:888-902.
21. Levine, M. M., D. Hone, C. Tacket, C. Ferreccio, and S. Cryz. 1990. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines. Res. Microbiol. 141:807-816.
22. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301-308.
23. Marchetii, M., B. Arico, D. Burroni, N. Figura, R. Rappuoli, and P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267:1655-1658.
24. Mekalanos, J. J. 1992. Bacterial mucosal vaccines. Adv. Exp. Med. Biol. 327:43-50.
25. Michetti, P., I. Corthésy-Theulaz, C. Davin, R. Haas, A. C. Vaney, M. Heitz, J. Bille, J. P. Kraehenbuhl, E. Saraga, and A. L. Blum. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107:1002-1011.
26. Michetti, P., C. Kreiss, K. Kotloff, N. Porta, J. L. Blanco, D. Bachmann, P. F. Saldinger, I. Corthésy-Theulaz, G. Losonsky, R. Nichols, M. Stolte, T. Monath, S. Ackerman, and A. L. Blum. 1997. Oral immunization of H. pylori infected adults with recombinant urease and LT adjuvant. Gastroenterology 112:A1042.
27. Miller, S. I., A. M. Kukral, and J. J. Mekalanos. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA 86:5054-5058.
28. Miller, S. I., and J. J. Mekalanos. 1990. Constitutive expression of the PhoP regulon attenuates Salmonella virulence and survival within macrophages. J. Bacteriol. 172:2485-2490.
29. Mohammadi, M., S. Czinn, R. Redline, and J. Nedrud. 1996. Helicobacter-specific cell-mediated immune responses display a predominant Th1 pheno-type and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:4729-4738.
30. Nardelli-Haefliger, D., J.-P. Kraehenbuhl, R. Curtiss III, F. Schödel, A. Potts, S. Kelly, and P. De Grandi. 1996. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect. Immun. 64:5219-5224.
31. Nardelli-Haefliger, D., R. B. S. Roden, J. Benyacoub, R. Sahli, J.-P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. De Grandi. 1997. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:3328-3336.
32. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
33. Sadoff, J. C., W. R. Ballou, L. S. Baron, W. R. Majarian, R. N. Brey, W. T. Hockmeyer, J. F. Young, S. J. Cryz, J. Ou, G. H. Lowell, and J. D. Chulay. 1988. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240:336-338.
34. Saldinger, P. F., N. Porta, P. Launois, J. A. Louis, G. A. Waanders, P. Michetti, A. L. Blum, and I. Corthésy-Theulaz. Mucosal immunization of BALB/c mice with Helicobacter urease B induces a T helper type 2 response not seen during infection with Helicobacter. Submitted for publication.
35. Schödel, F. 1990. Oral vaccination using recombinant bacteria. Semin. Immunol. 2:341-349.
36. + T cell response. J. Exp. Med. 181:961-971.
37. Tacket, C. O., D. M. Hone, R. Curtiss III, S. M. Kelly, G. Losonsky, L. Guers, A. M. Harris, R. Edelman, and M. M. Levine. 1992, Comparison of the safety and immunogenicity of ΔaroC ΔaroD and Δcya Δcrp Salmonella typhi strains in adult volunteers. Infect. Immun. 60:536-541.
38. Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452-456.
39. Thomas, H. C., and M. V. Parrott. 1974. The induction of tolerance to a soluble protein antigen by oral administration. Immunology 27:631-639.
40. VanCott, J. L., H. F. Staats, D. W. Pascual, M. Roberts, S. N. Chatfield, M. Yamamoto, M. Coste, P. B. Carter, H. Kiyono, and J. R. McGhee. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156:1504-1514.
41. Weltzin, R., H. Kleanthous, F. Guirakhoo, T. P. Monath, and C. K. Lee. 1997. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 15:370-376.
42. Wotherspoon, A. C., C. Ortiz-Hidalgo, M. R. Falzon, and P. G. Isaacson. 1991, Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176.
43. Yan, Z. X., and T. F. Meyer. 1994. The variation antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines. Behring Inst. Mitt. 95:49-54.
44. Yan, Z. X., F. Reuss, and T. F. Meyer. 1990. Construction of an invertible DNA segment for improved antigen expression by a hybrid Salmonella vaccine strain. Res. Microbiol. 141:1003-1004.